This trial has been completed.

Conditions diabetes screening, hyperlipidemia screening, hypertension screening
Treatment worksite screening for dm, htn and hyperlipidemia
Sponsor Mayo Clinic
Start date April 2015
End date September 2016
Trial size 40 participants
Trial identifier NCT02418637, 15-000647


Test the feasibility of performing worksite screening of Hypertension, Diabetes and Hyperlipidemia for six months

United States No locations recruiting
Other countries No locations recruiting

Study Design

Intervention model single group assignment
Masking open label
Primary purpose prevention
This is a one arm intervention including farm workers and owners
worksite screening for dm, htn and hyperlipidemia
Six monthly visits to worksite to perform screenings

Primary Outcomes

Feasibility (Likert scale)
time frame: After six months of the intervention, the outcome will be assessed on the last site visit via questionnaire

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - 18 years and older - agricultural workers and farm owners Exclusion Criteria:

Additional Information

Official title Worksite Screening for Cardiovascular Risk Factors Among Migrant Agricultural Workers
Principal investigator M Murad, MD
Description The investigators will be visiting farmers at the worksite monthly for six month and perform cardiovascular risk factors screening: blood pressure, blood glucose, glycosylated hemoglobin and cholesterol. At the end of this intervention, the investigators will test the feasibility of this approach among this specific population through questionnaires.
Trial information was received from ClinicalTrials.gov and was last updated in November 2016.
Information provided to ClinicalTrials.gov by Mayo Clinic.